BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

612 related articles for article (PubMed ID: 11238621)

  • 1. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo.
    Hara M; Kingsley CI; Niimi M; Read S; Turvey SE; Bushell AR; Morris PJ; Powrie F; Wood KJ
    J Immunol; 2001 Mar; 166(6):3789-96. PubMed ID: 11238621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses.
    Kingsley CI; Karim M; Bushell AR; Wood KJ
    J Immunol; 2002 Feb; 168(3):1080-6. PubMed ID: 11801641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD25+ CD4+ T cells regulate the expansion of peripheral CD4 T cells through the production of IL-10.
    Annacker O; Pimenta-Araujo R; Burlen-Defranoux O; Barbosa TC; Cumano A; Bandeira A
    J Immunol; 2001 Mar; 166(5):3008-18. PubMed ID: 11207250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role for thymic and splenic regulatory CD4+ T cells induced by donor dendritic cells in allograft tolerance by LF15-0195 treatment.
    Chiffoleau E; BĂ©riou G; Dutartre P; Usal C; Soulillou JP; Cuturi MC
    J Immunol; 2002 May; 168(10):5058-69. PubMed ID: 11994458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colitogenic Th1 cells are present in the antigen-experienced T cell pool in normal mice: control by CD4+ regulatory T cells and IL-10.
    Asseman C; Read S; Powrie F
    J Immunol; 2003 Jul; 171(2):971-8. PubMed ID: 12847269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viral IL-10-induced immunosuppression requires Th2 cytokines and impairs APC function within the allograft.
    Qin L; Ding Y; Tahara H; Bromberg JS
    J Immunol; 2001 Feb; 166(4):2385-93. PubMed ID: 11160297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutting edge: CD4+CD25+ alloantigen-specific immunoregulatory cells that can prevent CD8+ T cell-mediated graft rejection: implications for anti-CD154 immunotherapy.
    van Maurik Av; Herber M; Wood KJ; Jones ND
    J Immunol; 2002 Nov; 169(10):5401-4. PubMed ID: 12421913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokines affecting CD4(+) T regulatory cells in transplant tolerance. Interleukin-4 does not maintain alloantigen specific CD4(+)CD25(+) Treg.
    Plain KM; Verma ND; Tran GT; Nomura M; Boyd R; Robinson CM; Hodgkinson SJ; Hall BM
    Transpl Immunol; 2013 Dec; 29(1-4):51-9. PubMed ID: 24139939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory T cells induced by 1 alpha,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance.
    Gregori S; Casorati M; Amuchastegui S; Smiroldo S; Davalli AM; Adorini L
    J Immunol; 2001 Aug; 167(4):1945-53. PubMed ID: 11489974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alloantigen-induced CD25+CD4+ regulatory T cells can develop in vivo from CD25-CD4+ precursors in a thymus-independent process.
    Karim M; Kingsley CI; Bushell AR; Sawitzki BS; Wood KJ
    J Immunol; 2004 Jan; 172(2):923-8. PubMed ID: 14707064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A role for TGF-beta in the generation and expansion of CD4+CD25+ regulatory T cells from human peripheral blood.
    Yamagiwa S; Gray JD; Hashimoto S; Horwitz DA
    J Immunol; 2001 Jun; 166(12):7282-9. PubMed ID: 11390478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-signal blockade with anti-CD45RB and anti-CD154 monoclonal antibodies inhibits graft rejection via CD4-dependent mechanisms in allogeneic skin transplantation.
    Kim EY; Lee EN; Lee J; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Joh JW; Kim SJ
    Exp Mol Med; 2006 Jun; 38(3):284-94. PubMed ID: 16819287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type 2 immune deviation has differential effects on alloreactive CD4+ and CD8+ T cells.
    Matesic D; Valujskikh A; Pearlman E; Higgins AW; Gilliam AC; Heeger PS
    J Immunol; 1998 Nov; 161(10):5236-44. PubMed ID: 9820495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Both CD4(+)CD25(+) and CD4(+)CD25(-) regulatory cells mediate dominant transplantation tolerance.
    Graca L; Thompson S; Lin CY; Adams E; Cobbold SP; Waldmann H
    J Immunol; 2002 Jun; 168(11):5558-65. PubMed ID: 12023351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IFN-gamma production by alloantigen-reactive regulatory T cells is important for their regulatory function in vivo.
    Sawitzki B; Kingsley CI; Oliveira V; Karim M; Herber M; Wood KJ
    J Exp Med; 2005 Jun; 201(12):1925-35. PubMed ID: 15967822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of murine inflammatory bowel disease by CD25+ and CD25- CD4+ glucocorticoid-induced TNF receptor family-related gene+ regulatory T cells.
    Uraushihara K; Kanai T; Ko K; Totsuka T; Makita S; Iiyama R; Nakamura T; Watanabe M
    J Immunol; 2003 Jul; 171(2):708-16. PubMed ID: 12847237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of transplantation tolerance converts potential effector T cells into graft-protective regulatory T cells.
    Francis RS; Feng G; Tha-In T; Lyons IS; Wood KJ; Bushell A
    Eur J Immunol; 2011 Mar; 41(3):726-38. PubMed ID: 21243638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B7 interactions with CD28 and CTLA-4 control tolerance or induction of mucosal inflammation in chronic experimental colitis.
    Liu Z; Geboes K; Hellings P; Maerten P; Heremans H; Vandenberghe P; Boon L; van Kooten P; Rutgeerts P; Ceuppens JL
    J Immunol; 2001 Aug; 167(3):1830-8. PubMed ID: 11466409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of antigen-specific immunologic tolerance by in vivo and in vitro antigen-specific expansion of naturally arising Foxp3+CD25+CD4+ regulatory T cells.
    Nishimura E; Sakihama T; Setoguchi R; Tanaka K; Sakaguchi S
    Int Immunol; 2004 Aug; 16(8):1189-201. PubMed ID: 15237110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-CD4-mediated selection of Treg in vitro - in vitro suppression does not predict in vivo capacity to prevent graft rejection.
    Oliveira V; Sawitzki B; Chapman S; Appelt C; Gebuhr I; Wieckiewicz J; Long E; Wood KJ
    Eur J Immunol; 2008 Jun; 38(6):1677-88. PubMed ID: 18465768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.